These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 1692708)
1. Correlation of cytokeratin patterns with histopathology during neoplastic progression in the rat urinary bladder. Reedy EA; Heatfield BM; Trump BF; Resau JH Pathobiology; 1990; 58(1):15-27. PubMed ID: 1692708 [TBL] [Abstract][Full Text] [Related]
2. Discrimination of cell types in primary transitional cell carcinoma by monoclonal anti-cytokeratin antibodies. Reedy EA; Colombo-Burke KL; Resau JH Pathobiology; 1990; 58(6):304-11. PubMed ID: 1706601 [TBL] [Abstract][Full Text] [Related]
3. Detection of residual tumor cells in bladder biopsy specimens: pitfalls in the interpretation of cytokeratin stains. Tamas EF; Epstein JI Am J Surg Pathol; 2007 Mar; 31(3):390-7. PubMed ID: 17325480 [TBL] [Abstract][Full Text] [Related]
4. Correlation of DNA ploidy levels with altered cytokeratin patterns in rat bladder tumors. Reedy EA; Cottrell JR; Resau JH Pathobiology; 1991; 59(2):62-8. PubMed ID: 1713770 [TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical Expression of Cyclin D1, Cytokeratin 20, and Uroplakin III in Proliferative Urinary Bladder Lesions Induced by o-Nitroanisole in Fischer 344/N Rats. Willson CJ; Flake GP; Sills RC; Kissling GE; Cesta MF Vet Pathol; 2016 May; 53(3):682-90. PubMed ID: 26319780 [TBL] [Abstract][Full Text] [Related]
6. Expression of cytokeratin 20 in urinary cytology of patients with bladder carcinoma. Klein A; Zemer R; Buchumensky V; Klaper R; Nissenkorn I Cancer; 1998 Jan; 82(2):349-54. PubMed ID: 9445193 [TBL] [Abstract][Full Text] [Related]
7. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653 [TBL] [Abstract][Full Text] [Related]
8. Characterization of an N-methyl-N-nitrosourea-induced autochthonous rat bladder cancer model. Steinberg GD; Brendler CB; Ichikawa T; Squire RA; Isaacs JT Cancer Res; 1990 Oct; 50(20):6668-74. PubMed ID: 2208131 [TBL] [Abstract][Full Text] [Related]
9. Squamous and transitional elements in rat bladder carcinomas induced by N-butyl-N-4-hydroxybutyl-nitrosamine (BBN). A study of cytokeratin expression. Herman CJ; Vegt PD; Debruyne FM; Vooijs GP; Ramaekers FC Am J Pathol; 1985 Sep; 120(3):419-26. PubMed ID: 2412446 [TBL] [Abstract][Full Text] [Related]
10. NTP Toxicology and Carcinogenesis Studies of o-Nitroanisole (CAS No. 91-23-6) in F344 Rats and B6C3F1 Mice (Feed Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1993 May; 416():1-482. PubMed ID: 12616295 [TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical study of keratin in proliferative bladder epithelium induced by freezing, cyclophosphamide or N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide in the rat. Hasegawa R; Cohen SM Carcinogenesis; 1985 Mar; 6(3):409-14. PubMed ID: 2579745 [TBL] [Abstract][Full Text] [Related]
12. Coordinate expression of cytokeratins 7 and 20 in prostate adenocarcinoma and bladder urothelial carcinoma. Bassily NH; Vallorosi CJ; Akdas G; Montie JE; Rubin MA Am J Clin Pathol; 2000 Mar; 113(3):383-8. PubMed ID: 10705819 [TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical detection of uroplakin III, cytokeratin 7, and cytokeratin 20 in canine urothelial tumors. Ramos-Vara JA; Miller MA; Boucher M; Roudabush A; Johnson GC Vet Pathol; 2003 Jan; 40(1):55-62. PubMed ID: 12627713 [TBL] [Abstract][Full Text] [Related]
14. Transitional cell neoplasms of the ovary and urinary bladder: a comparative immunohistochemical analysis. Soslow RA; Rouse RV; Hendrickson MR; Silva EG; Longacre TA Int J Gynecol Pathol; 1996 Jul; 15(3):257-65. PubMed ID: 8811388 [TBL] [Abstract][Full Text] [Related]
15. Coordinate expression of cytokeratins 7 and 20 in feline and canine carcinomas. Espinosa de los Monteros A; Fernández A; Millán MY; Rodríguez F; Herráez P; Martín de las Mulas J Vet Pathol; 1999 May; 36(3):179-90. PubMed ID: 10332826 [TBL] [Abstract][Full Text] [Related]
16. Cyclin D1 overexpression in rat two-stage bladder carcinogenesis and its relationship with oncogenes, tumor suppressor genes, and cell proliferation. Lee CC; Yamamoto S; Wanibuchi H; Wada S; Sugimura K; Kishimoto T; Fukushima S Cancer Res; 1997 Nov; 57(21):4765-76. PubMed ID: 9354438 [TBL] [Abstract][Full Text] [Related]
17. [Coordinated expression of cytokeratin 7 and 20 in transitional carcinoma of the bladder: diagnostic usefulness]. Cid Mouteira P; Ortíz Rey JA; Antón Badiola I; San Miguel Fraile P; Alvarez Alvarez C; Zungri Telo E; de la Fuente Buceta A Actas Urol Esp; 2002 Apr; 26(4):279-84. PubMed ID: 12090187 [TBL] [Abstract][Full Text] [Related]
18. The "promoting" activity of methyl methanesulphonate in rat bladder carcinogenesis. Tudor RJ; Severs NJ; Hicks RM Br J Cancer; 1984 Jul; 50(1):63-75. PubMed ID: 6743515 [TBL] [Abstract][Full Text] [Related]
19. Proteomics and immunohistochemistry define some of the steps involved in the squamous differentiation of the bladder transitional epithelium: a novel strategy for identifying metaplastic lesions. Celis JE; Celis P; Ostergaard M; Basse B; Lauridsen JB; Ratz G; Rasmussen HH; Orntoft TF; Hein B; Wolf H; Celis A Cancer Res; 1999 Jun; 59(12):3003-9. PubMed ID: 10383167 [TBL] [Abstract][Full Text] [Related]
20. N-methyl-N-nitrosourea induces dysplasia and cell surface markers of neoplasia in long-term rat bladder organ cultures. Knowles MA; Jani H; Hicks RM; Berry RJ Carcinogenesis; 1985 Jul; 6(7):1047-54. PubMed ID: 4017171 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]